This paper, co-written by Pacific Northwest Node Lead Investigator Dennis Donovan, as well as Dennis Daley, Greg Brigham, and colleagues, currently in-press in the Journal of Substance Abuse Treatment, reports on the primary outcomes of National Drug Abuse Treatment Clinical Trials Network protocol CTN-0031. Our node served as the Lead Node for this project, working with CTPs and researchers from the ATS, FNA, OV, PR, SC, TX, and WS nodes.
The study evaluated the effectiveness of an 8-week combined group plus individual 12-step facilitative intervention on stimulant drug use and 12-step meeting attendance and service. Individuals were randomized into treatment as usual (TAU) or TAU into which the STAGE-12 intervention was integrated. Assessments were carried out at baseline, mid-treatment, end of treatment, and 3- and 6- month post-randomization follow-ups.
Conclusions: Though the findings were mixed with respect to the impact of integrating the STAGE-12 intervention into intensive outpatient drug treatment compared with TAU on stimulant drug use, the results more clearly indicate that individuals in STAGE-12, compared to those in TAU, have higher rates of 12-step meeting attendance and engage in more related activities throughout both the active treatment phase and the entire 6-month follow-up.
Congratulations to all the Pacific Northwest Node researchers and community treatment providers who participated in this protocol!
Citation: Donovan DM, Daley CD, Brigham GS, et al. Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): A Multisite Trial in the National Institute on Drug Abuse Clinical Trials Network. Journal of Substance Abuse Treatment 2012 (in press).